In Lisbon, ESC Preventive Cardiology 2025 brings together experts dedicated to enhancing preventive measures in cardiology. Attendees will gain insights into evidence-based approaches, community health strategies, and innovative technologies improving patient outcomes. Our team will present research addressing key challenges in prevention and discuss collaboration opportunities to drive impactful solutions. Let’s meet to explore shared goals in advancing preventive care.
Richmond Pharmacology Appoints Dr Daniel Chapple as Commercial Director
July 13, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Dr Daniel Chapple PhD FCIM as Commercial Director.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
